[ASAP] Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021 / acs. Molpharmaceut. 2c01036. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon